课题基金 / 基金详情

Research for relationship between infectiosity and amino acid sequences of hepatitis C virus from human inocula and transmitted chimpanzee sera

Research for relationship between infectiosity and amino acid sequences of hepatitis C virus from human inocula and transmitted chimpanzee sera
人接种物和传播黑猩猩血清丙型肝炎病毒传染性与氨基酸序列关系的研究
批准号:
06670241
负责人:
SUGITANI Masahiko
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

SUGITANI Masahiko的其他基金

相似基金

相关文献

中文摘要
翻译
我们分析了4种血清中丙型肝炎病毒(HCV)高变区(HVR)的核酸和氨基酸序列,为下一步用黑猩猩进行滴定实验的研究做准备。随后将稀释度为10^<-5>、10^<-3>和10^<-2>的人血清#4分别接种给编号为364,346和345的黑猩猩,随后将稀释度为10^<-4>、10^<-5>和10^<-6>的人血清#6分别接种给编号为353,215和340的黑猩猩。只有353号和215号黑猩猩血清中HCV RNA呈阳性,而接种4号和接种6号均含有高滴度的HCV RNA(通过半定量竞争测定,每个接种2 × 10^6拷贝/ml)。提取RNA,转录成cDNA,扩增,采集20个菌落,测定核酸和氨基酸序列。4号和6号克隆的遗传变异主要局限于HVR区。4号和6号分别有6个和4个克隆,并且4号克隆与6号克隆的氨基酸序列不同(表1和2)。另一方面,克隆的黑猩猩353号和215号在氨基酸序列上完全相同。来自这两只黑猩猩的所有克隆的同源性与人类接种物#6的主要类型(6a-1)相同。滴定实验结果表明,血清中HCV RNA滴度与体内传染性并不一定相关,氨基酸序列分析研究表明,稀释后接种的主要群克隆主要以传播和复制为主。
英文摘要
We analyzed nucleic and amino acid sequences of the hypervariable region (HVR) of the hepatitis C virus (HCV) in the 4 kinds of sera, for the study of the next step of the titration experiments using chimpanzees as follows. One ml each of 10^<-5>,10^<-3> and 10^<-2> dilutions of human serum #4 were subsequently inoculated to chimpanzees nos.364,346, and 345, respectively, and one ml of 10^<-4>,10^<-5>, and 10^<-6> dilutions of human serum #6 were subsequently inoculated to chimpanzee nos.353,215, and 340, respectively. Only chimpanzee nos.353 and 215 were positive for HCV RNA in the sera, while both of inocula #4 and #6 contained high titer of HCV RNA (2x10^6 copies/ml, each, by semi-quantitative competitive assay). RNA extraction, transcription to cDNA,and amplification were done, 20 colonies were picked up, and nucleic and amino acid sequences were determined. Genetic variations were limited mostly to the HVR region in clones from #4 and #6. There were 6 and 4 clones from #4 and #6, respectively, and clones from #4 were different from those from #6 in amino acid sequences (table 1 & 2). On the other hand, clones of chimpanzee nos.353 and 215 were completely same in amino acid sequences. Homology of all clones from both chimpanzees was identical to the major type (6a-1) of human inoculum #6. The results of titration experiment suggested that HCV RNA titer in sera was not always correlate with in vivo infectivity, and the analytical study of amino acid sequences suggested that major group clone in the diluted inocula were mainly transmitted and replicated.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
厚生省非A非B型肝炎研究斑: "日本人C型肝炎患者血清感染性のタイトレーション実験" 肝臓. 35. 887-891 (1994)
卫生福利部非甲、非乙型肝炎研究领域:“日本丙型肝炎患者血清感染性滴定实验”肝35。887-891(1994)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
厚生省 非A非B型肝炎研究班: "日本人C型肝炎患者血清感染性のタイトレーション実験" 肝臓. 35. 887-891 (1994)
卫生福利部非甲、非乙型肝炎研究组:“日本丙型肝炎患者血清感染性滴定实验”肝35。887-891(1994)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
杉谷雅彦,阿部賢治,志方俊夫: "チンパンジーを用いたHCV感染実験" 肝臓. 36. 330-333 (1995)
Masahiko Sugitani、Kenji Abe、Toshio Shikata:“使用黑猩猩进行 HCV 感染实验” 肝脏。36. 330-333 (1995)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
厚生省非A非B型肝炎研究班: "日本人C型肝炎患者血清感染性のタイトレーション実験" 肝臓. 35. 887-891 (1994)
卫生福利部非甲、非乙型肝炎研究组:《日本丙型肝炎患者血清感染性滴定实验》肝。 35. 887-891 (1994)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 7 条
    Epidemiological survey and immunological and molecular pathological study of hepatocellular adenoma in Japan
    • 批准号:
      26460461
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2014
    • 负责人:
      SUGITANI Masahiko
    • 依托单位:
    Research of genetic analysis. of hepatitis C virus clones and immune response in reinfection experiment using chimpanzees.
    • 批准号:
      14570203
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.73万
    • 财政年份:
      2002
    • 负责人:
      SUGITANI Masahiko
    • 依托单位:
    国内基金
    海外基金
    Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
    • 批准号:
      82371801
    • 项目类别:
      面上项目
    • 资助金额:
      47.00万元
    • 批准年份:
      2023
    • 负责人:
      周海波
    • 依托单位:
    Pik3r2基因突变在家族内侧颞叶癫痫中的作用及发病机制研究
    • 批准号:
      82371454
    • 项目类别:
      面上项目
    • 资助金额:
      47.00万元
    • 批准年份:
      2023
    • 负责人:
      郝勇
    • 依托单位:
    22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
    • 批准号:
      82370906
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      代杰文
    • 依托单位:
    发展基因编码的荧光探针揭示趋化因子CXCL10的时空动态及其调控机制